These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5818983)

  • 41. [Aplastic anemia induced by chloramphenicol--clinical studies].
    Okubo H; Okamoto Y; Fujii Y
    Nihon Rinsho; 1978 Jul; 36(7):2728-33. PubMed ID: 702864
    [No Abstract]   [Full Text] [Related]  

  • 42. Chloramphenicol-induced aplastic anaemia--should its topical use be abandoned?
    Tan LK
    Singapore Med J; 1999 Jul; 40(7):445-6. PubMed ID: 10560268
    [No Abstract]   [Full Text] [Related]  

  • 43. The chloramphenicol--hepatitis--aplastic anaemia syndrome.
    Hodgkinson R
    Med J Aust; 1973 May; 1(19):939-40. PubMed ID: 4715401
    [No Abstract]   [Full Text] [Related]  

  • 44. [Course and prognosis of aplastic anemia induced by chloramphenicol].
    Manny N; Izak G
    Harefuah; 1975 Jun; 88(11):507-9. PubMed ID: 1158196
    [No Abstract]   [Full Text] [Related]  

  • 45. Fatal aplastic anemia following apparent "dose-related" chloramphenicol toxicity.
    Daum RS; Cohen DL; Smith AL
    J Pediatr; 1979 Mar; 94(3):403-6. PubMed ID: 423022
    [No Abstract]   [Full Text] [Related]  

  • 46. A prospective study of chloramphenicol induced aplastic anaemia in Nigerians.
    Durosinmi MA; Ajayi AA
    Trop Geogr Med; 1993; 45(4):159-61. PubMed ID: 8236465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The relationship between drug exposure and acquired aplastic anemia].
    Lin GW
    Zhonghua Nei Ke Za Zhi; 1986 Jan; 25(1):3-6, 62. PubMed ID: 3731952
    [No Abstract]   [Full Text] [Related]  

  • 48. Aplastic anemia in Shiraz, an analysis of 50 cases with special reference to etiological agents in Southwest Iran.
    Banihashemi A; Kohout E; Hedayatee H
    Blut; 1973 Jan; 26(1):20-6. PubMed ID: 4683627
    [No Abstract]   [Full Text] [Related]  

  • 49. [Aplastic anemia after chloramphenicol therapy].
    Ritland S; Frogn W
    Tidsskr Nor Laegeforen; 1970 Jul; 90(14):1484-6. PubMed ID: 5452276
    [No Abstract]   [Full Text] [Related]  

  • 50. [Bone marrow damage caused by chloramphenicol].
    Ruvidić R
    Srp Arh Celok Lek; 1969 May; 97(3):345-56. PubMed ID: 4908993
    [No Abstract]   [Full Text] [Related]  

  • 51. Fatal aplastic anemia and chloramphenicol.
    Clarke WT
    Can Med Assoc J; 1967 Sep; 97(13):815. PubMed ID: 6050902
    [No Abstract]   [Full Text] [Related]  

  • 52. [Aplastic anemia caused by chloramphenicol].
    Popadić M; Surbat G
    Med Arh; 1968; 22(5):33-7. PubMed ID: 5194588
    [No Abstract]   [Full Text] [Related]  

  • 53. [Acquired aplastic anemia, with special consideration of complications and prognosis].
    Muller C; Ganzoni AM
    Schweiz Med Wochenschr; 1970 Mar; 100(10):441-50. PubMed ID: 4912612
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical and hematological aspects of chloramphenicol-associated aplastic anemia (author's transl)].
    Muto Y; Takaku F
    Rinsho Ketsueki; 1977 Jun; 18(6):684-8. PubMed ID: 916197
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter: Chloramphenicol eye-drops and marrow aplasia.
    Carpenter G
    Lancet; 1975 Aug; 2(7929):326-7. PubMed ID: 50539
    [No Abstract]   [Full Text] [Related]  

  • 56. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.
    Flach AJ
    Am J Ophthalmol; 1982 Sep; 94(3):420-2. PubMed ID: 7124889
    [No Abstract]   [Full Text] [Related]  

  • 57. [Palmyelopathy following chloramphenicol (author's transl)].
    Weingärtner L; Exadaktylos P
    Klin Padiatr; 1974 Sep; 186(5):394-407. PubMed ID: 4475314
    [No Abstract]   [Full Text] [Related]  

  • 58. Aplastic anemia associated with intravenous chloramphenicol.
    Alavi JB
    Am J Hematol; 1983 Dec; 15(4):375-9. PubMed ID: 6650496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restricting topical ocular chloramphenicol eye drop use in the United States. Did we overreact?
    Fraunfelder FW; Fraunfelder FT
    Am J Ophthalmol; 2013 Sep; 156(3):420-422. PubMed ID: 23953152
    [No Abstract]   [Full Text] [Related]  

  • 60. [Need for limitation and rational administration of chloramphenicol-containing drugs].
    Pstragowska W
    Pediatr Pol; 1973 Aug; 48(8):1033-9. PubMed ID: 4585106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.